Hunstein W - Search Results

1

Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis.

Mereles D, Buss SJ, Hardt SE, Hunstein W, Katus HA. Mereles D, et al. Among authors: hunstein w. Clin Res Cardiol. 2010 Aug;99(8):483-90. doi: 10.1007/s00392-010-0142-x. Epub 2010 Mar 10. Clin Res Cardiol. 2010. PMID: 20221615

2

Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?

Mereles D, Hunstein W. Mereles D, et al. Among authors: hunstein w. Int J Mol Sci. 2011;12(9):5592-603. doi: 10.3390/ijms12095592. Epub 2011 Aug 31. Int J Mol Sci. 2011. PMID: 22016611 Free PMC article. Review.

3

670 nm laser light and EGCG complementarily reduce amyloid-β aggregates in human neuroblastoma cells: basis for treatment of Alzheimer's disease?

Sommer AP, Bieschke J, Friedrich RP, Zhu D, Wanker EE, Fecht HJ, Mereles D, Hunstein W. Sommer AP, et al. Among authors: hunstein w. Photomed Laser Surg. 2012 Jan;30(1):54-60. doi: 10.1089/pho.2011.3073. Epub 2011 Oct 26. Photomed Laser Surg. 2012. PMID: 22029866

4

The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection.

Hauber I, Hohenberg H, Holstermann B, Hunstein W, Hauber J. Hauber I, et al. Among authors: hunstein w. Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9033-8. doi: 10.1073/pnas.0811827106. Epub 2009 May 18. Proc Natl Acad Sci U S A. 2009. PMID: 19451623 Free PMC article.

5

Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma.

Haas R, Moos M, Karcher A, Möhle R, Witt B, Goldschmidt H, Frühauf S, Flentje M, Wannenmacher M, Hunstein W. Haas R, et al. Among authors: hunstein w. J Clin Oncol. 1994 Aug;12(8):1685-92. doi: 10.1200/JCO.1994.12.8.1685. J Clin Oncol. 1994. PMID: 7518860

6

Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site.

Körbling M, Holle R, Haas R, Knauf W, Dörken B, Ho AD, Kuse R, Pralle H, Fliedner TM, Hunstein W. Körbling M, et al. Among authors: hunstein w. J Clin Oncol. 1990 Jun;8(6):978-85. doi: 10.1200/JCO.1990.8.6.978. J Clin Oncol. 1990. PMID: 1971851

7

Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen.

Ho AD, Lipp T, Ehninger G, Illiger HJ, Meyer P, Freund M, Hunstein W. Ho AD, et al. Among authors: hunstein w. J Clin Oncol. 1988 Feb;6(2):213-7. doi: 10.1200/JCO.1988.6.2.213. J Clin Oncol. 1988. PMID: 3422260

8

Epigallocathechin-3-gallate in AL amyloidosis: a new therapeutic option?

Hunstein W. Hunstein W. Blood. 2007 Sep 15;110(6):2216. doi: 10.1182/blood-2007-05-089243. Blood. 2007. PMID: 17785589 Free article. No abstract available.

9

Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia.

Körbling M, Hunstein W, Fliedner TM, Cayeux S, Dörken B, Fehrentz D, Haas R, Ho AD, Keilholz U, Knauf W, et al. Körbling M, et al. Among authors: hunstein w. Blood. 1989 Nov 1;74(6):1898-904. Blood. 1989. PMID: 2804340 Free article.

10

Autologous blood stem cell transplantation for patients with Hodgkin's disease in sensitive relapse.

Haas R, Hohaus S, Ehrhardt R, Ogniben E, Boschmann G, Witt B, Hunstein W. Haas R, et al. Among authors: hunstein w. Prog Clin Biol Res. 1992;377:621-7. Prog Clin Biol Res. 1992. PMID: 1359569 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters